(Q34225114)

31 July 2017

1 reference

title

Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands (English)

1 reference

31 July 2017

0 references

Horowitz MC

1

1 reference

31 July 2017

Xi Y

series ordinal

2

1 reference

31 July 2017

Wilson K

series ordinal

3

1 reference

31 July 2017

Kacena MA

series ordinal

4

1 reference

31 July 2017

publication date

1 March 2001

1 reference

Cytokine and Growth Factor Reviews

31 July 2017

published in

1 reference

31 July 2017

volume

12

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

9-18

1 reference

31 July 2017

cites work

Mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Modulation of osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Regulation of osteoclast function

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Osteoblastic cells are involved in osteoclast formation.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Characterization of structural domains of human osteoclastogenesis inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Tumor necrosis factor-alpha and -beta upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

cAMP stimulates osteoblast-like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Cytokines and estrogen in bone: anti-osteoporotic effects

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

The cell-surface form of colony-stimulating factor-1 is regulated by osteotropic agents and supports formation of multinucleated osteoclast-like cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Genetic linkage of familial expansile osteolysis to chromosome 18q

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900030-7

7 January 2021

10.1016/S1359-6101(00)00030-7

Identifiers

DOI

1 reference

31 July 2017

1 reference